NASDAQ

Intellipharmaceutics to Present at the Biotech Showcase™

TORONTO, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I)("Intellipharmaceutics" or the ...

Assembly Biosciences Appoints Biotech Veteran Alan J. Lewis to Board of Directors

INDIANAPOLIS, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company ...

Xeris Pharmaceuticals Announces $41 Million Series C Financing

Austin, Texas, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc., a specialty biopharmaceutical ...

Prothena Announces Addition of Seasoned Executive to Board of Directors

DUBLIN, Ireland, June 29, 2015 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage ...

Conatus Pharmaceuticals Appoints Jean L. Chan as Vice President, Clinical Development

SAN DIEGO, June 8, 2015 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology ...

PhaseBio Pharmaceuticals Announces Positive Data for Type 2 Diabetes Treatments PE0139 and PB1023

PE0139 was well tolerated; pharmacokinetic / pharmacodynamic profile supports once-weekly dosing PE0139 demonstrated synergistic ...

AMAG Pharmaceuticals Announces New Senior Management Appointments

WALTHAM, Mass., June 2, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced ...

Type 2 Diabetes Trial Results Published In Diabetes Care

NEW YORK and MELBOURNE, Australia, July 22, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; ...